[Efficacy of levofloxacin 500 mg for middle ear diseases].

Takashi Kimitsuki, Takamasa Yoshida, Shizuo Komune

Research output: Contribution to journalArticle

Abstract

We examined the cases that prescribed levofloxacin (LVFX) 500mg for middle ear diseases in our hospital. LVFX 500mg was prescribed in 18 cases (7 male, 11 female, 24-81 years old). LVFX was mainly used for the following clinical conditions, 1) otitis media with granulation proliferation: 3 cases, 2) infection to an artificial materials : 5 cases, 3) treatment for or prevention against the inflammation of the inner ear: 4 cases. Three of eighteen cases were ineffective by LVFX treatment. Bacteriological examination indicated LVFX-resistant MRSA or Pseudomonas aeruginosa were isolated in these three cases.

Original languageEnglish
Pages (from-to)43-48
Number of pages6
JournalFukuoka igaku zasshi = Hukuoka acta medica
Volume103
Issue number2
Publication statusPublished - Feb 2012

Fingerprint

Ear Diseases
Levofloxacin
Middle Ear
Otitis Media
Inner Ear
Methicillin-Resistant Staphylococcus aureus
Pseudomonas aeruginosa
Inflammation
Infection

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Kimitsuki, T., Yoshida, T., & Komune, S. (2012). [Efficacy of levofloxacin 500 mg for middle ear diseases]. Fukuoka igaku zasshi = Hukuoka acta medica, 103(2), 43-48.

[Efficacy of levofloxacin 500 mg for middle ear diseases]. / Kimitsuki, Takashi; Yoshida, Takamasa; Komune, Shizuo.

In: Fukuoka igaku zasshi = Hukuoka acta medica, Vol. 103, No. 2, 02.2012, p. 43-48.

Research output: Contribution to journalArticle

Kimitsuki, T, Yoshida, T & Komune, S 2012, '[Efficacy of levofloxacin 500 mg for middle ear diseases].', Fukuoka igaku zasshi = Hukuoka acta medica, vol. 103, no. 2, pp. 43-48.
Kimitsuki, Takashi ; Yoshida, Takamasa ; Komune, Shizuo. / [Efficacy of levofloxacin 500 mg for middle ear diseases]. In: Fukuoka igaku zasshi = Hukuoka acta medica. 2012 ; Vol. 103, No. 2. pp. 43-48.
@article{7b79cf14ab28498388b5c19b647e13c3,
title = "[Efficacy of levofloxacin 500 mg for middle ear diseases].",
abstract = "We examined the cases that prescribed levofloxacin (LVFX) 500mg for middle ear diseases in our hospital. LVFX 500mg was prescribed in 18 cases (7 male, 11 female, 24-81 years old). LVFX was mainly used for the following clinical conditions, 1) otitis media with granulation proliferation: 3 cases, 2) infection to an artificial materials : 5 cases, 3) treatment for or prevention against the inflammation of the inner ear: 4 cases. Three of eighteen cases were ineffective by LVFX treatment. Bacteriological examination indicated LVFX-resistant MRSA or Pseudomonas aeruginosa were isolated in these three cases.",
author = "Takashi Kimitsuki and Takamasa Yoshida and Shizuo Komune",
year = "2012",
month = "2",
language = "English",
volume = "103",
pages = "43--48",
journal = "Fukuoka Acta Medica",
issn = "0016-254X",
publisher = "福岡医学会",
number = "2",

}

TY - JOUR

T1 - [Efficacy of levofloxacin 500 mg for middle ear diseases].

AU - Kimitsuki, Takashi

AU - Yoshida, Takamasa

AU - Komune, Shizuo

PY - 2012/2

Y1 - 2012/2

N2 - We examined the cases that prescribed levofloxacin (LVFX) 500mg for middle ear diseases in our hospital. LVFX 500mg was prescribed in 18 cases (7 male, 11 female, 24-81 years old). LVFX was mainly used for the following clinical conditions, 1) otitis media with granulation proliferation: 3 cases, 2) infection to an artificial materials : 5 cases, 3) treatment for or prevention against the inflammation of the inner ear: 4 cases. Three of eighteen cases were ineffective by LVFX treatment. Bacteriological examination indicated LVFX-resistant MRSA or Pseudomonas aeruginosa were isolated in these three cases.

AB - We examined the cases that prescribed levofloxacin (LVFX) 500mg for middle ear diseases in our hospital. LVFX 500mg was prescribed in 18 cases (7 male, 11 female, 24-81 years old). LVFX was mainly used for the following clinical conditions, 1) otitis media with granulation proliferation: 3 cases, 2) infection to an artificial materials : 5 cases, 3) treatment for or prevention against the inflammation of the inner ear: 4 cases. Three of eighteen cases were ineffective by LVFX treatment. Bacteriological examination indicated LVFX-resistant MRSA or Pseudomonas aeruginosa were isolated in these three cases.

UR - http://www.scopus.com/inward/record.url?scp=84861815468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861815468&partnerID=8YFLogxK

M3 - Article

C2 - 22568127

AN - SCOPUS:84861815468

VL - 103

SP - 43

EP - 48

JO - Fukuoka Acta Medica

JF - Fukuoka Acta Medica

SN - 0016-254X

IS - 2

ER -